The latest cancer drugs news
Browsing: Cancer Drug News
ESMO 2020: PARP inhibitor olaparib for the targeted treatment of metastatic prostate cancer
Results from the PROfound phase III study, funded by AstraZeneca and Merck Sharp & Dohme,…
ESMO 2020: First new drug in years reduces recurrence in high-risk hormone receptor positive early breast cancer
Adding abemaciclib to hormonal therapy reduces the risk of cancer recurrence by 25% in patients…
ESMO 2020: Access to cancer medicines and clinical trials show stark variations across Europe
Access to cancer medicines is highly unequal across Europe both for new drugs in development…
Immunotherapy improves survival in advanced bladder cancer patients
Immunotherapy drug avelumab has been shown to significantly improve survival in patients with the most…
Combining two precision medicines can treat drug-resistant cancers
Launching a dual-pronged attack on tumours using a combination of two innovative precision medicines could…
FDA approves pralsetinib for lung cancer with RET gene fusions
The Food and Drug Administration granted accelerated approval to pralsetinib for adult patients with metastatic…
FDA approves azacitidine tablets for acute myeloid leukaemia
On September 1, 2020, the Food and Drug Administration approved azacitidine tablets (ONUREG) for continued…
First drug-like compounds to inhibit elusive cancer-linked enzymes developed
A team of scientists from the University of Michigan Rogel Cancer Center, USA, has developed…
Strong, durable responses to selpercatinib in RET-driven medullary thyroid cancer
Selpercatinib (Retevmo), a drug targeted precisely against cancers driven by mutations or alterations in the…
Phase 1 human trials suggest breast cancer drug is safe and effective
A new type of breast cancer drug developed by researchers at the University of Illinois…